Volitionrx Ltd
VNRX- Exchange
- NYSE
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000093314
No open-market purchases or sales by Volitionrx Ltd insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $2.61M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Volitionrx Ltd as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- +5 vs. Q3 2024
- Shares held
- 18.7M
- +1.16M (+6.6%) vs. Q3 2024
- Total value
- $11.2M
- +$677.5K (+6.4%) vs. Q3 2024
- New holders
- 8
- 7 more added
- Sold out
- 3
- 5 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VNRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 24 | $2.61M |
| Q1 2026 | 31 | $4.52M |
| Q4 2025 | 28 | $4.13M |
| Q3 2025 | 33 | $17.7M |
| Q2 2025 | 29 | $18.2M |
| Q1 2025 | 25 | $12.0M |
| Q4 2024 | 27 | $11.2M |
| Q3 2024 | 22 | $10.5M |
| Q2 2024 | 27 | $4.84M |
| Q1 2024 | 24 | $5.89M |
| Q4 2023 | 28 | $4.56M |
| Q3 2023 | 30 | $4.35M |
| Q2 2023 | 34 | $8.99M |
| Q1 2023 | 38 | $12.2M |
| Q4 2022 | 34 | $15.1M |
| Q3 2022 | 34 | $8.02M |
| Q2 2022 | 31 | $12.2M |
| Q1 2022 | 34 | $18.3M |
| Q4 2021 | 37 | $18.7M |
| Q3 2021 | 39 | $19.2M |
| Q2 2021 | 47 | $21.4M |
| Q1 2021 | 57 | $33.0M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Volitionrx Ltd; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 377 | $0 | 0.00% | +22+6.2% | Added |
| Royal Bank of Canada | 10 | $0 | 0.00% | +10 | New |
| Allworth Financial LP | 200 | $123 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 265 | $159 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 588 | $353 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1,481 | $889 | 0.00% | +1,481 | New |
| Founders Capital Management | 2,000 | $1.20K | 0.00% | 00.0% | Unchanged |
| Hartford Financial Management Inc. | 5,000 | $3.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 8,579 | $5.15K | 0.00% | +1,834+27.2% | Added |
| Morgan Stanley | 10,900 | $6.54K | 0.00% | +8,000+275.9% | Added |
| Susquehanna International Group, LLP | 11,324 | $6.79K | 0.00% | −45,292−80.0% | Reduced |
| Virtu Financial LLC | 12,248 | $7.00K | 0.00% | +12,248 | New |
| Bridgeway Capital Management, LLC | 20,280 | $12.2K | 0.00% | −3,900−16.1% | Reduced |
| XTX Topco Ltd | 21,359 | $12.8K | 0.00% | +21,359 | New |
| Creative Planning | 23,211 | $13.9K | 0.00% | +23,211 | New |
| Two Sigma Securities, LLC | 48,910 | $29.3K | 0.01% | +48,910 | New |
| Millennium Management LLC | 60,638 | $36.4K | 0.00% | +60,638 | New |
| Citadel Advisors LLC | 68,192 | $40.9K | 0.00% | +68,192 | New |
| UBS Group AG | 107,349 | $64.4K | 0.00% | −8,445−7.3% | Reduced |
| Northern Trust Corp | 117,875 | $70.7K | 0.00% | +28,579+32.0% | Added |
| Silverberg Bernstein Capital Management LLC | 133,913 | $80.3K | 0.07% | −8,705−6.1% | Reduced |
| State Street Corp | 147,638 | $88.6K | 0.00% | +23,715+19.1% | Added |
| BlackRock, Inc. | 445,187 | $267.1K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 636,667 | $382.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 743,843 | $446.4K | 0.00% | +13,395+1.8% | Added |
| Lagoda Investment Management, L.P. | 7,576,000 | $4.55M | 2.46% | +1,481,000+24.3% | Added |
| Armistice Capital, LLC | 8,481,895 | $5.09M | 0.12% | −516,832−5.7% | Reduced |
| Ground Swell Capital, LLC | 0 | $0 | 0.00% | −45,959−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −4,400−100.0% | Sold out |
| Larson Financial Group LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |